Brainstorm Cell Therapeutics plans to launch a Phase 3b trial to test NurOwn against a placebo in about 200 people with mild ...

Columnist Kristin Neva and her husband, Todd, marked the 15-year anniversary of his ALS diagnosis with a rare outing and ...

High-dose dazucorilant patients who went into the open-label extension saw an 84% lower risk of death over those who didn't ...

Learn when to consider a feeding tube for ALS, how it supports nutrition, what you can still eat or drink, and options tailored to your needs.

Living with ALS presents unique challenges. Columnist Dagmar Munn implements a mental shift that helps her ride the ups and downs.